References
- Lopes CV, Hela M, Pesenti C et al. Circumferential endoscopic resection of Barrett’s esophagus with high-grade dysplasia or early adenocarcinoma. Surg. Endosc.21(5), 820–824 (2007).
- Ell C, May A, Pech O et al. Curative endoscopic resection of early esophageal adenocarcinomas (Barrett’s cancer). Gastrointest. Endosc.65(1), 3–10 (2007).
- Collard JM. High-grade dysplasia in Barrett’s esophagus. The case for esophagectomy. Chest Surg. Clin. N. Am.12(1), 77–92 (2002).
- Reed MF, Tolis G, Jr., Edil BH et al. Surgical treatment of esophageal high-grade dysplasia. Ann. Thorac. Surg.79(4), 1110–1115 (2005).
- Van Laethem JL, Peny MO, Salmon I, Cremer M, Deviere J. Intramucosal adenocarcinoma arising under squamous re-epithelialisation of Barrett’s oesophagus. Gut46(4), 574–577 (2000).
- Bergman JJ. Diagnosis and therapy of early neoplasia in Barrett’s esophagus. Curr. Opin. Gastroenterol.21(4), 466–471 (2005).
- Ell C, May A, Gossner L et al. Endoscopic mucosal resection of early cancer and high-grade dysplasia in Barrett’s esophagus. Gastroenterology118(4), 670–677 (2000).
- Nijhawan PK, Wang KK. Endoscopic mucosal resection for lesions with endoscopic features suggestive of malignancy and high-grade dysplasia within Barrett’s esophagus. Gastrointest. Endosc.52(3), 328–332 (2000).
- Inoue H, Endo M, Takeshita K et al. A new simplified technique of endoscopic esophageal mucosal resection using a cap-fitted panendoscope (EMRC). Surg. Endosc.6(5), 264–265 (1992).
- Nigro JJ, Hagen JA, DeMeester TR et al. Prevalence and location of nodal metastases in distal esophageal adenocarcinoma confined to the wall: implications for therapy. J. Thorac. Cardiovasc. Surg.117(1), 16–23 (1999).
- Swisher SG, Deford L, Merriman KW et al. Effect of operative volume on morbidity, mortality, and hospital use after esophagectomy for cancer. J. Thorac. Cardiovasc. Surg.119(6), 1126–1132 (2000).
- van Lanschot JJ, Hulscher JB, Buskens CJ et al. Hospital volume and hospital mortality for esophagectomy. Cancer91(8), 1574–1578 (2001).
- Karl RC, Schreiber R, Boulware D, Baker S, Coppola D. Factors affecting morbidity, mortality, and survival in patients undergoing Ivor Lewis esophagogastrectomy. Ann. Surg.231(5), 635–643 (2000).
- Young MM, Deschamps C, Trastek VF et al. Esophageal reconstruction for benign disease: early morbidity, mortality, and functional results. Ann. Thorac. Surg.70(5), 1651–1655 (2000).
- Stein HJ, Feith M, Mueller J, Werner M, Siewert JR. Limited resection for early adenocarcinoma in Barrett’s esophagus. Ann. Surg.232(6), 733–742 (2000).
- Holscher AH, Bollschweiler E, Schneider PM, Siewert JR. Early adenocarcinoma in Barrett’s oesophagus. Br. J. Surg.84(10), 1470–1473 (1997).
- Sampliner RE. Updated guidelines for the diagnosis, surveillance, and therapy of Barrett’s esophagus. Am. J. Gastroenterol.97(8), 1888–1895 (2002).
- Hirota WK, Zuckerman MJ, Adler DG et al. ASGE guideline: the role of endoscopy in the surveillance of premalignant conditions of the upper GI tract. Gastrointest. Endosc.63(4), 570–580 (2006).
- Buskens CJ, Westerterp M, Lagarde SM et al. Prediction of appropriateness of local endoscopic treatment for high-grade dysplasia and early adenocarcinoma by EUS and histopathologic features. Gastrointest. Endosc.60(5), 703–710 (2004).
- Bergman JJ. Endoscopic mucosal resection for treatment of high-grade dysplasia and early cancer in Barrett’s esophagus. Rose BD (Ed.). Up To Date, MA, USA (2007).